Substance Abuse Prevention Act of 2018

S.892 Opioid Addiction Prevention Act of 2017 H.R.4408 - Opioid Addiction Prevention Act of 2017 H.R.3964 - Opioid Addiction Prevention Act of 2017 H.R. 5219 - Opioid Prescription Verification Act H.R. 4275 - Empowering Pharmacists in the Fight Against Opioids Act H.R. 4275 - Safe Disposal of Unused Medication Act H.R. 2063 - Opioid Preventing Abuse through Continuing Education Act S. 3120 Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018 S. 2789, Substance Abuse Prevention Act of 2018 S. 2838, Using Data to Prevent Opioid Diversion Act of 2018 S. 2460, Every Prescription Conveyed Security Act of 2018 H.R. 5812, Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act (CONNECTIONS) Act H.R. 4275, Empowering Pharmacists in the Fight Against Opioid Abuse Act H.R. 3528, Every Prescription Conveyed Securely Act H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R. 5675, To amend title XVIII of the Social Security Act to require prescription drug plan sponsors under the Medicare program to establish drug management programs for at-risk beneficiaries H.R. 5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act H.R. 5687, Securing Opioids and Unused Narcotics with Deliberate Disposal and Packaging Act H.R.6 - SUPPORT for Patients and Communities Act S. 2465 - AIDD Act S 2837 - Preventing Drug Diversion Act S. 3282 - DEA Order Clearinghouse Act S. 2383 - Using Data to Prevent Opioid Diversion Act

Client expense: $640,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 62, the Gun Violence Reduction Resources Act, would authorize the hiring of an additional 200 agents and investigators for the Bureau of Alcohol, Tobacco, Firearms and Explosives in the U.S. Department of Justice; H.R. 115/S. 1085, the Thin Blue Line Act, would increase the penalty for offenders who kill or attempt to kill law enforcement or other public safety officers; H.R. 426/S. 1087, the Protecting Lives Using Surplus (PLUS) Equipment Act, which would restore all Federal equipment assistance programs to State and local law enforcement which were restricted by Executive Order 13688; H.R. 613/S. 1084, the Lieutenant Osvaldo Albarati Correctional Officer Self-Protection Act, would direct the Bureau of Prisons to make secure firearms storage areas accessible to employees at all of its facilities; H.R. 622, the Local Law Enforcement for Local Lands Act, would terminate the law enforcement functions of the U.S. Forest Service and the Bureau of Land Management; H.R. 664, the Stem the Tide of Overdose Prevalence from Opiate Drugs (STOP OD) Act, would aim to reduce the curb the number of overdoses due to synthetic fentanyl and helps equip law enforcement officers with naloxone; H.R. 909/S. 322, the Pet and Women Safety (PAWS) Act, would expand existing Federal protections to the pets of domestic abuse victims and establish a grant program to assist victims and their pets when they leave their abusers; H.R. 1039/S. 367, the Probation Officer Protection Act, which would amend section 3606 of Title 18, United States Code, to grant probation officers authority to arrest hostile third parties who obstruct or impede a probation officer in the performance of official duties; H.R. 1057/S. 372, the Synthetics Trafficking and Overdose Prevention (STOP) Act would close the loophole and allow U.S Border and Customs Protections to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 1494/S. 654, the Preventing Animal Cruelty and Torture Act which would provide criminal penalty for those who engage in animal crushing, as well as for those who create or distribute such films; H.R. 1498, the End Racial Profiling Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search-absent an eyewitness description-and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; H.R. 1636, the School Safety Act, which would reauthorize and expand the Secure Our Schools program administered by the Office of Community Oriented Policing Services (COPS); H.R. 1732, the Synthetic Drug Control Act, which would enhance the ability of law enforcement to combat synthesized drugs by amending the Controlled Substances Act to clarify how controlled substance analogues are to be regulated; H.R. 1761, the Protection Against Child Exploitation Act, which would close an existing loophole in current statute by clarifying certain definitions in child pornography law; H.R. 1886/S. 573, the National Criminal Justice Commission Act, which would establish National Criminal Justice Commission to study the nations criminal justice systems; H.R. 1979, the No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act, which would significantly limit States who fund anti-drug task forces from receiving Federal funding from the Edward J. Byrne Memorial Justice Assistant Grants program; H.R. 2213, the Anti-Bordering Corruption Reauthorization Act, which would improve the ability of the U.S. Customs and Border Patrol to hire new officers; H.R. 2437/S. 1134, the Back the Blue Act, which contains a number of amendments to Federal law expanding the death penalty for persons who kill law enforcement officers, restrictions on habeas corpus, limitation on recovery of damages incurred during an arrest as well as two amendments to the Law Enforcement Officers Safety Act (LEOSA) with respect to magazine capacity and the Guns Free School Zones Act; H.R. 2513, the Police Officers Protecting Children Act, which would add qualified active and retired law enforcement officers, as defined by the Law Enforcement Officers Safety Act (LEOSA), to the list of exemptions to the Guns Free School Zones Act; H.R. 2561, the Protecting Police Officers of the Law in Civilian Establishments Act, which would clarify that existing Federal laws which prohibit the carriage of firearms onto Federal property like post offices, Social Security offices and Veterans Affairs offices do not apply to law enforcement officers in uniform; H.R. 2851/S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; H.R. 3003, Section 2, the "No Sanctuary for Criminals Act, which would penalize law enforcement agencies by withholding Federal fudning from so-called sanctuary cities; H.R. 3089/S. 1454/S. 1717, the Corporate Transparency Act, would require the Federal government to collect beneficial ownership information for corporations and limited liability companies unless the State already collects this information; H.R. 3790/S. 1854, the Federal Firearms Licensee Protection Act, which would increase penalties on those who burglarize or rob a Federal Firearms Licensee; H.R. 4471/S. 2492, the NICS Denial Notification Act, would require the U.S. Department of Justice to notify State and local law enforcement agencies if a prohibited person attempts to purchase a firearm in their jurisdiction; H.R. 4768/S. 2715, the National Strategy for Combating the Financing of Transnational Criminal Organizations Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; H.R. 4854/S. 2345, the Justice Served Act, which will increase the capacity of prosecutors to address the backlog of violent crime cases involving suspects identified through DNA evidence; H.R. 5060, the Heroes Lesley Zerebney and Gilbert Vega First Responders Survivors Support Act, which would increase the amount of the death benefit provide by the Public Safety Officers benefits (PSOB) program as well as other benefits administered by the PSOB; H.R. 5219, the Opioid Prescription Verification Act, which would require retail sellers of opioids to verify the identity of the purchaser; H.R. 5682 (as introduced), the Formerly Incarcerated Reenter Society Transformed Safely Transitioning Every Person (FIRST STEP) Act, which may result in the premature release of thousands of convicted offenders; H.R. 5698/S. 2794, the Protect and Serve Act, which would make it a Federal crime to target a law enforcement with an assault that results in seriously bodily harm or death; H.R. 5788, the Securing the International Mail Against Opioids Act, which would close the loophole and allow U.S Custom and Border Protection to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 5871/S. 2763, the "Providing Officers with Electronic Resources (POWER) Act, which would establishes a grant program to be administered by the Office of Community Oriented Policing Services (COPS) in order to provide State and local law enforcement agencies with portable chemical screening devices to detect dangerous synthetic opioids and other drugs; S. 207, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, would close the existing loophole for the manufacturers on analogue drug sales and distribution; S. 318, the COPS Improvement Act, would reauthorize the Office of Community Oriented Policing Services (COPS) and improve its existing hiring program; S. 446, the Constitutional Concealed Carry Reciprocity Act, which would allow any civilian concealed carry permit holder to travel to any other State issuing concealed carry permits without any training or safety requirements; S. 739, the Protecting Kids from Candy-Flavored Drugs Act, would impose increased prison sentences on adults who manufacture, create, distribute, or possess with the intent to distribute a controlled substance that is appealing to kids, whether designed or flavored; S. 748, the Protecting the Rights of Families and Immigrants Who Legally Entered From Detention (PROFILED) Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search, absent an eyewitness description, and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; S. 1241, the Combating Money Laundering, Terrorist Financing, and Counterfeiting Act, which would update and strengthen Federal laws to combat money laundering and provide law enforcement with additional tools to restrict the ability of criminals to profit from their crimes; S. 1311, the Abolish Human Trafficking Act, reauthorizes parts of the Trafficking Victims Protection Act and expand the authority of State and local agencies to obtain wiretap warrants for trafficking investigations; S. 1312, the Trafficking Victims Protection Act, would help prevent human trafficking by promoting training for law enforcement and school resource officers through the Office of Community Oriented Policing Services (COPS) to better identify and respond to human trafficking victims; S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; S. 1666, the "Helping Overcome Trauma for Children Alone in Rear Seats (HOTCARS) Act, which would direct the U.S. Department of Transportation to implement a rule requiring vehicles to notify drivers if a child or other passenger has been inadvertently left behind; S. 1781, the National White Collar Crime Control Act, which would reauthorize grant programs to law enforcement to combat white collar crimes; S. 2389, Erics Law, which would amend current law to allow Federal prosecutors to impanel a second jury for the sentencing phase of capital cases; S. 2715, the Criminal Organizations Narcotics, Finance, Resources, Operations and Network Targeting (CONFRONT) Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; S. 2759, the EAGLES Act, which would reauthorize the National Threat Asessment Center (NTAC) within the U.S. Department of Homeland Security; S. 2774, which would reauthorize the Office of Community Oriented Policing Services (COPS) within the U.S. Department of Justice through 2023; S. 2789, the "Substance Abuse Prevention Act, which would reauthorize the Office of National Drug Control Policy and the programs it administers; S. 2973, the Kelsey Smith Act, which would require telephone companies and wireless carriers to disclose cell-site location data without a warrant in certain exigent circumstances; Legislation which would protect the personal information of law enforcement officers and their families from public access; Legislation or amendments that would have the effect of weakening PL 106-185, the Civil Asset Forfeiture Reform Act of 2000; Legislation which would create or fund civilian review boards of law enforcement at any level of government; and Legislation which would further normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.

S. 2460, Every Prescription Conveyed Securely Act (Bennet) - opioid issues S. 2680, Opioid Crisis Response Act (Alexander) - opioid initiatives, mental health parity S. 2789, Substance Abuse Prevention Act (Cornyn) - opioid initiatives, restrictions on step therapy S. 2812, Air Ambulance Consumer Protection Act (McCaskill) - air ambulance S. 2828, Sober Home Fraud Detection Act (Rubio) - best practices for identifying fraud in recovery housing S. 2891, Fighting the Opioid Epidemic with Sunshine Act (Grassley) - opioid issues S. 2892, Peer Support Enhancement and Evaluation Review Act (Cardin) - opioid issues S. 2898, Medication-Assisted Treatment Improvement Act (Casey) - opioid issues S. 2899, Caring Recovery for Infants and Babies Act (Brown) - opioid issues S. 2900, Comprehensive Screenings for Seniors Act (Brown) - opioid issues S. 2902, Better Data Sharing to Combat the Opioid Crisis Act (Cassidy) - opioid issues S. 2905, Strengthening Partnerships to Prevent Opioid Abuse Act (Toomey) - opioid issues S. 2910, Telehealth for Childrens Access to Services and Treatment Act (Roberts) - opioid issues S. 2911, Enhancing Patient Access to Non-Opioid Treatment Options (Heller) - opioid issues S. 2912, Opioid Addiction Treatment Programs Enhancement Act (Cassidy) - opioid issues S. 2920, Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act (McCaskill) - opioid issues S. 2922, Help for Moms and Babies Act (Stabenow) - opioid issues S. 2923, Building Capacity for Family-Focused Residential Treatment Act (Grassley) - opioid issues S. 2924, Supporting Family-Focused Residential Treatment Act (Scott) - opioid issues S. 3016, Action for Dental Health Act (Booker) - grants for oral health programs S. 3120, the HEAL Substance Use Disorders Act (Hatch) - opioid initiatives S. 3158, Labor-HHS-Education Appropriations Act (Blunt) - HHS funding S. 3254, Eliminating Kickbacks in Recovery Act (Rubio) - anti-kickback penalties for body brokers Draft Bill: Protecting Patients From Surprise Medical Bills Act (Cassidy) - surprise medical bills H.R. 6, SUPPORT Patients and Families Act (Walden) - opioid initiatives, Medicare and Medicaid issues, budget offsets H.R. 302, FAA Reauthorization Act - air ambulance issues H.R. 1215, Protecting Access to Care Act (King) - medical liability reform H.R. 1313, Preserving Employee Wellness Programs Act (Foxx) - employee wellness programs H.R. 2422, Action for Dental Health Act (Kelly) - oral health services and education for underserved populations H.R. 3331, adoption and use of EHR technology by behavioral health providers (Jenkins) - opioid issues H.R. 3528, Every Prescription Conveyed Securely Act (Clark) - opioid issues H.R. 4684, Ensuring Access to Quality Sober Living Act (Chu) - best practices for recovery housing H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act (Schweikert) - opioid issues H.R. 4998, Health Insurance for Former Foster Youth Act (Bass) - opioid issues H.R. 5100, Recovery Home Certification Act (Knight) -- anti-kickback penalties for body brokers H.R. 5477, Rural DOCS Act (O'Halleran) - opioid issues H.R. 5515, National Defense Authorization Act (Thornberry) H.R. 5562, Protecting NAS Babies Act (Jenkins) - opioid issues H.R. 5582, Abuse Deterrent Access Act (Carter) - opioid issues H.R. 5583, State reporting on certain adult health quality measures (Clarke) - opioid issues H.R. 5590, CMS Action Plan (Kinzinger) - opioid issues H.R. 5714, Education for Disposal of Unused Opioids Act (Black) - opioid issues H.R. 5715, Strengthening Partnerships to Prevent Opioid Abuse Act (Renacci) - opioid issues H.R. 5716, COMPASS Act (Roskam) - opioid issues H.R. 5723, Expanding Oversight of Opioid Prescribing and Payment Act (Tenney) - opioid issues H.R. 5725, BEST Act (Roskam) - opioid issues H.R. 5774, Combating Opioid Abuse for Care in Hospitals Act (Curbelo) - opioid issues H.R. 5775, Providing Reliable Options for Patients and Educational Resources Act (Paulsen) - opioid issues H.R. 5776, MOST Act (Neal) - opioid issues H.R. 5789, protections for pregnant and post-partum women (Foster) - opioid issues H.R. 5795, Overdose Prevention and Patient Safety Act (Blumenauer) - confidential sharing of substance use disorder information H.R. 5796, Responsible Education Achieves Care and Healthy Outcomes for Users' Treatment Act (Fitzpatrick) - opioid issues H.R. 5801, PARTNERSHIP Act (Griffith) - opioid issues H.R. 6082, Overdose Prevention and Patient Safety Act (Mullin) - confidential sharing of substance use disorder information H.R. 6147, Interior, Environment, Financial Services, Agriculture, FDA, Transportation, and Housing Appropriations Act (Calvert) - FDA funding H.R. 6157, Defense-Labor-HHS-Education Appropriations Act (Granger) - HHS funding H.R. 6753, Strengthening the Health Care Fraud Prevention Task Force Act (Walden) - codification of Healthcare Fraud Prevention Partnership H.R. 6878, Eliminating Kickbacks in Recovery Act (Deutch) - anti-kickback penalties for body brokers H.R. 6902, Eliminating Kickbacks in Recovery Act (Knight) - anti-kickback penalties for body brokers Regulatory Issues: HIPAA administrative simplification issues, including standards for privacy, security, and electronic transactions and code sets (including ICD-10), identifiers including the health plan identifier, enforcement; cybersecurity; FEHBP enrollment data clearinghouse initiative, the enrollment reconciliation process, and a related OPM reimbursement factor for records that cannot be reconciled; issues relating to health insurance plan participation in FEHBP, including contract requirements; issues relating to similarly sized subscriber group (SSSG) and MLR requirements under the FEHBP; implementation of the health savings account provisions of the Medicare Act; issues related to Medicare Secondary Payer requirements; issues related to implementation of the National Health Information Infrastructure; electronic health records, personal health records, and similar technologies; issues relating to market consolidation; issues related to hospital consolidation; issues relating to quality improvement; issues relating to the national health data stewardship; issues relating to hospital outpatient measurement and reporting; prescription drug pricing; issues related to the collection of race and ethnicity data; issues related to medical loss ratios; reference pricing; review of rates for reasonableness; preexisting condition insurance plans; issues relating to antitrust; accountable care organizations; provider non-discrimination; coverage of preventive services; contraceptive coverage; pre-existing condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; issues relating to the annual fee on health insurance providers; health plan automatic enrollment requirements; issues related to qualified health plans including certification and rate filing templates; health insurance market rules; reinsurance, risk corridors, and risk adjustment; dependent coverage; summary of benefits and coverage disclosures; benefit and payment parameters; essential health benefits, actuarial value, and accreditation; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations; issues related to supplemental products; issues related to HIPAA excepted benefits; issues related to short term limited duration products; issues related to the federally-facilitated marketplaces (i.e., Exchanges/formerly referred to as the web portal); issues related to business continuity in relation to pandemics or natural events (e.g., hurricane, tornado, etc.); issues related to association health plans; issues related to cost-sharing reductions (CSRs); issues related to the refundable credit for coverage under a qualified health plan; issues related to small employer group size; issues related to Certificate of Public Advantage; issues relating to veterans health care; issues relating to family caregivers; and other issues relating to health care reform implementation.

S. 1625, FY 2018 Consolidated Appropriations Act (Royce) - funding for HHS programs and agencies, opioid initiatives, ACA risk corridors S. 2460, Every Prescription Conveyed Securely Act (Bennet) - opioid issues S. 2680, Opioid Crisis Response Act (Alexander) - opioid initiatives, mental health parity S. 2789, Substance Abuse Prevention Act (Cornyn) - opioid initiatives, restrictions on step therapy S. 2812, Air Ambulance Consumer Protection Act (McCaskill) - air ambulance S. 2891, Fighting the Opioid Epidemic with Sunshine Act (Grassley) - opioid issues S. 2892, Peer Support Enhancement and Evaluation Review Act (Cardin) - opioid issues S. 2898, Medication-Assisted Treatment Improvement Act (Casey) - opioid issues S. 2899, Caring Recovery for Infants and Babies Act (Brown) - opioid issues S. 2900, Comprehensive Screenings for Seniors Act (Brown) - opioid issues S. 2902, Better Data Sharing to Combat the Opioid Crisis Act (Cassidy) - opioid issues S. 2905, Strengthening Partnerships to Prevent Opioid Abuse Act (Toomey) - opioid issues S. 2910, Telehealth for Childrens Access to Services and Treatment Act (Roberts) - opioid issues S. 2911, Enhancing Patient Access to Non-Opioid Treatment Options (Heller) - opioid issues S. 2912, Opioid Addiction Treatment Programs Enhancement Act (Cassidy) - opioid issues S. 2920, Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act (McCaskill) - opioid issues S. 2922, Help for Moms and Babies Act (Stabenow) - opioid issues S. 2923, Building Capacity for Family-Focused Residential Treatment Act (Grassley) - opioid issues S. 2924, Supporting Family-Focused Residential Treatment Act (Scott) - opioid issues S. 2987, National Defense Authorization Act (Inhofe) S. 3120, the HEAL Substance Use Disorders Act (Hatch) - opioid initiatives S. 3158, FY 2019 Labor, HHS, Education Appropriations Act (Blunt) - HHS funding, ACA issues House version of FY 2019 Labor, HHS, Education Appropriations Act (Cole) - HHS funding, ACA issues H.R. 6, SUPPORT Patients and Families Act (Walden) - opioid initiatives, budget offsets H.R. 1215, Protecting Access to Care Act (King) - medical liability reform H.R. 1313, Preserving Employee Wellness Programs Act (Foxx) - employee wellness programs H.R. 2422, Action for Dental Health Act (Kelly) - oral health services and education for underserved populations H.R. 3331, adoption and use of EHR technology by behavioral health providers (Jenkins) - opioid issues H.R. 3528, Every Prescription Conveyed Securely Act (Clark) - opioid issues H.R. 3759, RAISE Family Caregivers Act (Harper-Castor) - support for family caregivers H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act (Schweikert) - opioid issues H.R. 4998, Health Insurance for Former Foster Youth Act (Bass) - opioid issues H.R. 5477, Rural DOCS Act (O'Halleran) - opioid issues H.R. 5562, Protecting NAS Babies Act (Jenkins) - opioid issues H.R. 5582, Abuse Deterrent Access Act (Carter) - opioid issues H.R. 5583, State reporting on certain adult health quality measures (Clarke) - opioid issues H.R. 5590, CMS Action Plan (Kinzinger) - opioid issues H.R. 5515, National Defense Authorization Act (Thornberry) H.R. 5714, Education for Disposal of Unused Opioids Act (Black) - opioid issues H.R. 5715, Strengthening Partnerships to Prevent Opioid Abuse Act (Renacci) - opioid issues H.R. 5716, COMPASS Act (Roskam) - opioid issues H.R. 5723, Expanding Oversight of Opioid Prescribing and Payment Act (Tenney) - opioid issues H.R. 5725, BEST Act (Roskam) - opioid issues H.R. 5774, Combating Opioid Abuse for Care in Hospitals Act (Curbelo) - opioid issues H.R. 5775, Providing Reliable Options for Patients and Educational Resources Act (Paulsen) - opioid issues H.R. 5776, MOST Act (Neal) - opioid issues H.R. 5789, protections for pregnant and post-partum women (Foster) - opioid issues H.R. 5795, Overdose Prevention and Patient Safety Act (Blumenauer) - confidential sharing of substance use disorder information H.R. 5796, Responsible Education Achieves Care and Healthy Outcomes for Users' Treatment Act (Fitzpatrick) - opioid issues H.R. 5801, PARTNERSHIP Act (Griffith) - opioid issues H.R. 6082, Overdose Prevention and Patient Safety Act (Mullin) - confidential sharing of substance use disorder information Regulatory Issues: HIPAA administrative simplification issues, including standards for privacy, security, and electronic transactions and code sets (including ICD-10), identifiers including the health plan identifier, enforcement; cybersecurity; FEHBP enrollment data clearinghouse initiative, the enrollment reconciliation process, and a related OPM reimbursement factor for records that cannot be reconciled; issues relating to health insurance plan participation in FEHBP, including contract requirements; issues relating to similarly sized subscriber group (SSSG) and MLR requirements under the FEHBP; implementation of the health savings account provisions of the Medicare Act; issues related to Medicare Secondary Payer requirements; issues related to implementation of the National Health Information Infrastructure; electronic health records, personal health records, and similar technologies; issues relating to market consolidation; issues related to hospital consolidation; issues relating to quality improvement; issues relating to the national health data stewardship; issues relating to hospital outpatient measurement and reporting; prescription drug pricing; issues related to the collection of race and ethnicity data; issues related to medical loss ratios; reference pricing; review of rates for reasonableness; preexisting condition insurance plans; issues relating to antitrust; accountable care organizations; provider non-discrimination; coverage of preventive services; contraceptive coverage; pre-existing condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; issues relating to the annual fee on health insurance providers; health plan automatic enrollment requirements; issues related to qualified health plans including certification and rate filing templates; health insurance market rules; reinsurance, risk corridors, and risk adjustment; dependent coverage; summary of benefits and coverage disclosures; benefit and payment parameters; essential health benefits, actuarial value, and accreditation; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations; issues related to supplemental products; issues related to HIPAA excepted benefits; issues related to short term limited duration products; issues related to the federally-facilitated marketplaces (i.e., Exchanges/formerly referred to as the web portal); issues related to business continuity in relation to pandemics or natural events (e.g., hurricane, tornado, etc.); issues related to association health plans; issues related to cost-sharing reductions (CSRs); issues related to the refundable credit for coverage under a qualified health plan; issues related to small employer group size; issues related to Certificate of Public Advantage; issues relating to veterans health care; issues relating to family caregivers; and other issues relating to health care reform implementation.

Prescription drug abuse and misuse policy issues H.R. 2335 (114th Congress), the Stop Tampering of Prescription Pills Act: provisions related to approval of abuse-deterrent opioids H.R. 5127 (114th Congress), the Curb Opioid Misuse by Advancing Technology (COMBAT) Act: provisions related to encouraging the development of abuse-deterrent technology H.R. 4482, the Opioid Abuse Deterrence, Research, and Recovery Act: provisions related to the development of abuse-deterrent opioids Abuse-deterrent opioid policy issues Pain therapy access policy issues S. 2789, the Substance Abuse Prevention Act of 2018 regarding access to abuse-deterrent opioids

Client expense: $164,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Prescription drug abuse policy issues Provisions related to abuse-deterrent opioid formulary placement Provisions related to abuse-deterrent opioid coverage and access in Medicare H.R. 5582, the Abuse Deterrent Access Act regarding access to abuse-deterrent opioids in Medicare S. 2789, the Substance Abuse Prevention Act of 2018 regarding access to abuse-deterrent opioids

Client expense: $164,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Strengthening the Addiction Treatment Workforce Act (S. 1453), all provisions related to making addiction treatment centers eligible participating sites in the National Health Service Corps program. Improving Access to Mental Health Services Act (S. 2533), all provisions relating to allowing National Health Service Corps mental health professionals to deliver service in various community-based settings. Substance Use Disorder Workforce Loan Repayment Act (S. 2524/H.R. 5102), all provisions related to creating a federal student loan forgiveness program dedicated specifically to substance use disorder treatment professionals. Mental Health Professionals Workforce Shortage Loan Repayment Act of 2018 (H.R.6597), all provisions related to establishing a loan repayment program for mental health care providers in designated high-needs communities. The Special Registration for Telemedicine Clarification Act (H.R. 5483), all provisions related to establishing a special registration process with the Drug Enforcement Agency (DEA) for certain providers that wish to prescribe controlled substances via telemedicine. The Improving Access to Remote Behavioral Health Treatment Act of 2018 (H.R. 5594), all provision related to permitting community behavioral health care providers and Certified Community Behavioral Health Clinics to prescribe medications via telemedicine. Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act (H.R. 6), all provisions related to the expansion and/or enhancement of education, prevention, treatment and recovery supports services for substance use disorders and behavioral health providers operations. Opioid Crisis Response Act of 2018 (S. 2680), all provisions related to the expansion and/or enhancement of education, prevention, treatment and recovery supports services for substance use disorders. Improving Access to Behavioral Health Information Technology Act (S. 1732/H.R. 3331), all provisions related to tasking the Center for Medicare and Medicaid Innovation (CMMI) with creating a demonstration project to incentivize the use of EHR systems in various settings, including mental health and addiction treatment organizations. CHIP Mental Health Parity Act (H.R. 3192), all provisions related to ensuring equitable treatment coverage of mental illness and substance use disorder under the Childrens Health Insurance Program. Addiction Treatment Access Improvement Act (H.R. 3692/S. 2317), all provisions relating to what provider types would be allowed to prescribe buprenorphine and buprenorphine prescribing patient caps. Substance Abuse Prevention Act (S. 2789), all provisions relating to drug policy grant programs, including those administered by the Office of National Drug Control Policy (ONDCP) and the Department of Justice. National Suicide Prevention Hotline Improvement Act of 2017 (S. 1015/H.R. 2345), all provisions relating to the creation of three-digit code to assist individual experiencing mental health or substance use-related crises.

S.892 Opioid Addiction Prevention Act of 2017 H.R.4408 - Opioid Addiction Prevention Act of 2017 H.R.3964 - Opioid Addiction Prevention Act of 2017 H.R. 5219 - Opioid Prescription Verification Act H.R. 4275 - Empowering Pharmacists in the Fight Against Opioids Act H.R. 4275 - Safe Disposal of Unused Medication Act H.R. 2063 - Opioid Preventing Abuse through Continuing Education Act S. 3120 Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018 S. 2789, Substance Abuse Prevention Act of 2018 S. 2838, Using Data to Prevent Opioid Diversion Act of 2018 S. 2460, Every Prescription Conveyed Security Act of 2018 H.R. 5812, Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act (CONNECTIONS) Act H.R. 4275, Empowering Pharmacists in the Fight Against Opioid Abuse Act H.R. 3528, Every Prescription Conveyed Securely Act H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R. 5675, To amend title XVIII of the Social Security Act to require prescription drug plan sponsors under the Medicare program to establish drug management programs for at-risk beneficiaries H.R. 5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act H.R. 5687, Securing Opioids and Unused Narcotics with Deliberate Disposal and Packaging Act H.R.6 - SUPPORT for Patients and Communities Act S. 2465 - AIDD Act S 2837 - Preventing Drug Diversion Act S. 3282 - DEA Order Clearinghouse Act S. 2383 - Using Data to Prevent Opioid Diversion Act

Client expense: $440,000 · Firm income: Not reported

S.892 Opioid Addiction Prevention Act of 2017 H.R.4408 - Opioid Addiction Prevention Act of 2017 H.R.3964 - Opioid Addiction Prevention Act of 2017 H.R. 5219 - Opioid Prescription Verification Act H.R. 4275 - Empowering Pharmacists in the Fight Against Opioids Act H.R. 4275 - Safe Disposal of Unused Medication Act H.R. 2063 - Opioid Preventing Abuse through Continuing Education Act S. 3120 Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018 S. 2789, Substance Abuse Prevention Act of 2018 S. 2838, Using Data to Prevent Opioid Diversion Act of 2018 S. 2460, Every Prescription Conveyed Security Act of 2018 H.R. 5812, Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act (CONNECTIONS) Act H.R. 4275, Empowering Pharmacists in the Fight Against Opioid Abuse Act H.R. 3528, Every Prescription Conveyed Securely Act H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R. 5675, To amend title XVIII of the Social Security Act to require prescription drug plan sponsors under the Medicare program to establish drug management programs for at-risk beneficiaries H.R. 5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act H.R. 5687, Securing Opioids and Unused Narcotics with Deliberate Disposal and Packaging Act H.R.6 - SUPPORT for Patients and Communities Act

Client expense: $520,000 · Firm income: Not reported

Strengthening the Addiction Treatment Workforce Act (S. 1453), all provisions related to making addiction treatment centers eligible participating sites in the National Health Service Corps program. Improving Access to Mental Health Services Act (S. 2533), all provisions relating to allowing National Health Service Corps mental health professionals to deliver service in various community-based settings. Substance Use Disorder Workforce Loan Repayment Act (S. 2524/H.R. 5102), all provisions related to creating a federal student loan forgiveness program dedicated specifically to substance use disorder treatment professionals. The Special Registration for Telemedicine Clarification Act (H.R. 5483), all provisions related to establishing a special registration process with the Drug Enforcement Agency (DEA) for certain providers that wish to prescribe controlled substances via telemedicine. The Improving Access to Remote Behavioral Health Treatment Act of 2018 (H.R. 5594), all provision related to permitting community behavioral health care providers and Certified Community Behavioral Health Clinics to prescribe medications via telemedicine. Helping to End Addiction and Lessen Substance Use Disorders Act (HEAL Act) of 2018 (S. 3120), all provisions related to the expansion and/or enhancement of education, prevention, treatment and recovery supports services for substance use disorders. Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act (H.R. 6), all provisions related to the expansion and/or enhancement of education, prevention, treatment and recovery supports services for substance use disorders. Opioid Crisis Response Act of 2018 (S. 2680), all provisions related to the expansion and/or enhancement of education, prevention, treatment and recovery supports services for substance use disorders. Improving Access to Behavioral Health Information Technology Act (S. 1732/H.R. 3331), all provisions related to tasking the Center for Medicare and Medicaid Innovation (CMMI) with creating a demonstration project to incentivize the use of EHR systems in various settings, including mental health and addiction treatment organizations. CHIP Mental Health Parity Act (H.R. 3192), all provisions related to ensuring equitable treatment coverage of mental illness and substance use disorder under the Childrens Health Insurance Program. Addiction Treatment Access Improvement Act (H.R. 3692/S. 2317), select provisions relating to what provider types would be allowed to prescribe buprenorphine up the 275 patient cap. Mental Health in Schools Act (S. 1370/H.R. 2913), all provisions related to the implementation evidence-based programs for youth and young adults within the Substance Abuse and Mental Health Services Administration (SAMHSA). Substance Abuse Prevention Act (S. 2789), all provisions relating to drug policy grant programs, including those administered by the Office of National Drug Control Policy (ONDCP) and the Department of Justice. Comprehensive Addiction and Recovery Act (CARA) 2.0 of 2018 (S. 2456/ H.R. 5311), all provisions related to prevention, treatment, recovery, law enforcement, criminal justice and overdose reversal grant programs.

S. 1625, FY 2018 Consolidated Appropriations Act (Royce) - funding for HHS programs and agencies, opioid initiatives, ACA risk corridors S. 2460, Every Prescription Conveyed Securely Act (Bennet) - opioid issues S. 2680, Opioid Crisis Response Act (Alexander) - opioid initiatives, mental health parity S. 2789, Substance Abuse Prevention Act (Cornyn) - opioid initiatives, restrictions on step therapy S. 2812, Air Ambulance Consumer Protection Act (McCaskill) - air ambulance S. 2891, Fighting the Opioid Epidemic with Sunshine Act (Grassley) - opioid issues S. 2892, Peer Support Enhancement and Evaluation Review Act (Cardin) - opioid issues S. 2898, Medication-Assisted Treatment Improvement Act (Casey) - opioid issues S. 2899, Caring Recovery for Infants and Babies Act (Brown) - opioid issues S. 2900, Comprehensive Screenings for Seniors Act (Brown) - opioid issues S. 2902, Better Data Sharing to Combat the Opioid Crisis Act (Cassidy) - opioid issues S. 2905, Strengthening Partnerships to Prevent Opioid Abuse Act (Toomey) - opioid issues S. 2910, Telehealth for Childrens Access to Services and Treatment Act (Roberts) - opioid issues S. 2911, Enhancing Patient Access to Non-Opioid Treatment Options (Heller) - opioid issues S. 2912, Opioid Addiction Treatment Programs Enhancement Act (Cassidy) - opioid issues S. 2920, Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act (McCaskill) - opioid issues S. 2922, Help for Moms and Babies Act (Stabenow) - opioid issues S. 2923, Building Capacity for Family-Focused Residential Treatment Act (Grassley) - opioid issues S. 2924, Supporting Family-Focused Residential Treatment Act (Scott) - opioid issues S. 2987, National Defense Authorization Act (Inhofe) S. 3120, the HEAL Substance Use Disorders Act (Hatch) - opioid initiatives S. 3158, FY 2019 Labor, HHS, Education Appropriations Act (Blunt) - HHS funding, ACA issues House version of FY 2019 Labor, HHS, Education Appropriations Act (Cole) - HHS funding, ACA issues H.R. 6, SUPPORT Patients and Families Act (Walden) - opioid initiatives, budget offsets H.R. 1215, Protecting Access to Care Act (King) - medical liability reform H.R. 1313, Preserving Employee Wellness Programs Act (Foxx) - employee wellness programs H.R. 2422, Action for Dental Health Act (Kelly) - oral health services and education for underserved populations H.R. 3331, adoption and use of EHR technology by behavioral health providers (Jenkins) - opioid issues H.R. 3528, Every Prescription Conveyed Securely Act (Clark) - opioid issues H.R. 3759, RAISE Family Caregivers Act (Harper-Castor) - support for family caregivers H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act (Schweikert) - opioid issues H.R. 4998, Health Insurance for Former Foster Youth Act (Bass) - opioid issues H.R. 5477, Rural DOCS Act (O'Halleran) - opioid issues H.R. 5562, Protecting NAS Babies Act (Jenkins) - opioid issues H.R. 5582, Abuse Deterrent Access Act (Carter) - opioid issues H.R. 5583, State reporting on certain adult health quality measures (Clarke) - opioid issues H.R. 5590, CMS Action Plan (Kinzinger) - opioid issues H.R. 5515, National Defense Authorization Act (Thornberry) H.R. 5714, Education for Disposal of Unused Opioids Act (Black) - opioid issues H.R. 5715, Strengthening Partnerships to Prevent Opioid Abuse Act (Renacci) - opioid issues H.R. 5716, COMPASS Act (Roskam) - opioid issues H.R. 5723, Expanding Oversight of Opioid Prescribing and Payment Act (Tenney) - opioid issues H.R. 5725, BEST Act (Roskam) - opioid issues H.R. 5774, Combating Opioid Abuse for Care in Hospitals Act (Curbelo) - opioid issues H.R. 5775, Providing Reliable Options for Patients and Educational Resources Act (Paulsen) - opioid issues H.R. 5776, MOST Act (Neal) - opioid issues H.R. 5789, protections for pregnant and post-partum women (Foster) - opioid issues H.R. 5795, Overdose Prevention and Patient Safety Act (Blumenauer) - confidential sharing of substance use disorder information H.R. 5796, Responsible Education Achieves Care and Healthy Outcomes for Users' Treatment Act (Fitzpatrick) - opioid issues H.R. 5801, PARTNERSHIP Act (Griffith) - opioid issues H.R. 6082, Overdose Prevention and Patient Safety Act (Mullin) - confidential sharing of substance use disorder information Regulatory Issues: HIPAA administrative simplification issues, including standards for privacy, security, and electronic transactions and code sets (including ICD-10), identifiers including the health plan identifier, enforcement; cybersecurity; FEHBP enrollment data clearinghouse initiative, the enrollment reconciliation process, and a related OPM reimbursement factor for records that cannot be reconciled; issues relating to health insurance plan participation in FEHBP, including contract requirements; issues relating to similarly sized subscriber group (SSSG) and MLR requirements under the FEHBP; implementation of the health savings account provisions of the Medicare Act; issues related to Medicare Secondary Payer requirements; issues related to implementation of the National Health Information Infrastructure; electronic health records, personal health records, and similar technologies; issues relating to market consolidation; issues related to hospital consolidation; issues relating to quality improvement; issues relating to the national health data stewardship; issues relating to hospital outpatient measurement and reporting; prescription drug pricing; issues related to the collection of race and ethnicity data; issues related to medical loss ratios; reference pricing; review of rates for reasonableness; preexisting condition insurance plans; issues relating to antitrust; accountable care organizations; provider non-discrimination; coverage of preventive services; contraceptive coverage; pre-existing condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; issues relating to the annual fee on health insurance providers; health plan automatic enrollment requirements; issues related to qualified health plans including certification and rate filing templates; health insurance market rules; reinsurance, risk corridors, and risk adjustment; dependent coverage; summary of benefits and coverage disclosures; benefit and payment parameters; essential health benefits, actuarial value, and accreditation; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations; issues related to supplemental products; issues related to HIPAA excepted benefits; issues related to short term limited duration products; issues related to the federally-facilitated marketplaces (i.e., Exchanges/formerly referred to as the web portal); issues related to business continuity in relation to pandemics or natural events (e.g., hurricane, tornado, etc.); issues related to association health plans; issues related to cost-sharing reductions (CSRs); issues related to the refundable credit for coverage under a qualified health plan; issues related to small employer group size; issues related to Certificate of Public Advantage; issues relating to veterans health care; issues relating to family caregivers; and other issues relating to health care reform implementation.

Prescription drug abuse policy issues Provisions related to abuse-deterrent opioid formulary placement Provisions related to abuse-deterrent opioid coverage and access in Medicare H.R. 5582, the Abuse Deterrent Access Act regarding access to abuse-deterrent opioids in Medicare S. 2789, the Substance Abuse Prevention Act of 2018 regarding access to abuse-deterrent opioids

Client expense: $147,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Prescription drug abuse and misuse policy issues H.R. 2335 (114th Congress), the Stop Tampering of Prescription Pills Act: provisions related to approval of abuse-deterrent opioids H.R. 5127 (114th Congress), the Curb Opioid Misuse by Advancing Technology (COMBAT) Act: provisions related to encouraging the development of abuse-deterrent technology H.R. 4482, the Opioid Abuse Deterrence, Research, and Recovery Act: provisions related to the development of abuse-deterrent opioids Abuse-deterrent opioid policy issues Pain therapy access policy issues S. 2789, the Substance Abuse Prevention Act of 2018 regarding access to abuse-deterrent opioids

Client expense: $147,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 62, the Gun Violence Reduction Resources Act, would authorize the hiring of an additional 200 agents and investigators for the Bureau of Alcohol, Tobacco, Firearms and Explosives in the U.S. Department of Justice; H.R. 115/S. 1085, the Thin Blue Line Act, would increase the penalty for offenders who kill or attempt to kill law enforcement or other public safety officers; H.R. 426/S. 1087, the Protecting Lives Using Surplus (PLUS) Equipment Act, which would restore all Federal equipment assistance programs to State and local law enforcement which were restricted by Executive Order 13688; H.R. 613/S. 1084, the Lieutenant Osvaldo Albarati Correctional Officer Self-Protection Act, would direct the Bureau of Prisons to make secure firearms storage areas accessible to employees at all of its facilities; H.R. 622, the Local Law Enforcement for Local Lands Act, would terminate the law enforcement functions of the U.S. Forest Service and the Bureau of Land Management; H.R. 664, the Stem the Tide of Overdose Prevalence from Opiate Drugs (STOP OD) Act, would aim to reduce the curb the number of overdoses due to synthetic fentanyl and helps equip law enforcement officers with naloxone; H.R. 695/S. 705, the Child Protection Improvements Act, which would allow organizations that serve children and the elderly to use the FBI database to conduct background checks on potential employees; H.R. 909/S. 322, the Pet and Women Safety (PAWS) Act, would expand existing Federal protections to the pets of domestic abuse victims and establish a grant program to assist victims and their pets when they leave their abusers; H.R. 1039/S. 367, the Probation Officer Protection Act, which would amend section 3606 of Title 18, United States Code, to grant probation officers authority to arrest hostile third parties who obstruct or impede a probation officer in the performance of official duties; H.R. 1057/S. 372, the Synthetics Trafficking and Overdose Prevention (STOP) Act would close the loophole and allow U.S Border and Customs Protections to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 1494/S. 654, the Animal Cruelty and Torture Act which would provide criminal penalty for those who engage in animal crushing, as well as for those who create or distribute such films; H.R. 1498, the End Racial Profiling Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search-absent an eyewitness description-and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; H.R. 1636, the School Safety Act, which would reauthorize and expand the Secure Our Schools program administered by the Office of Community Oriented Policing Services (COPS); H.R. 1732, the Synthetic Drug Control Act, which would enhance the ability of law enforcement to combat synthesized drugs by amending the Controlled Substances Act to clarify how controlled substance analogues are to be regulated; H.R. 1761, the Protection Against Child Exploitation Act, which would close an existing loophole in current statute by clarifying certain definitions in child pornography law; H.R. 1865/S. 1693, the Allow States and Victims to Fight Online Sex Trafficking Act, which would to update and clarify Section 230 of the Communications Decency Act to ensure that charges can be brought against interactive computer service providers who engage in criminal behavior or with reckless disregard to criminal activity; H.R. 1886/S. 573, the National Criminal Justice Commission Act, which would establish National Criminal Justice Commission to study the nations criminal justice systems; H.R. 1979, the No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act, which would significantly limit States who fund anti-drug task forces from receiving Federal funding from the Edward J. Byrne Memorial Justice Assistant Grants program; H.R. 2213, the Anti-Bordering Corruption Reauthorization Act, which would improve the ability of the U.S. Customs and Border Patrol to hire new officers; H.R. 2437/S. 1134, the Back the Blue Act, which contains a number of amendments to Federal law expanding the death penalty for persons who kill law enforcement officers, restrictions on habeas corpus, limitation on recovery of damages incurred during an arrest as well as two amendments to the Law Enforcement Officers Safety Act (LEOSA) with respect to magazine capacity and the Guns Free School Zones Act; H.R. 2513, the Police Officers Protecting Children Act, which would add qualified active and retired law enforcement officers, as defined by the Law Enforcement Officers Safety Act (LEOSA), to the list of exemptions to the Guns Free School Zones Act; H.R. 2561, the Protecting Police Officers of the Law in Civilian Establishments Act, which would clarify that existing Federal laws which prohibit the carriage of firearms onto Federal property like post offices, Social Security offices and Veterans Affairs offices do not apply to law enforcement officers in uniform; H.R. 2851/S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; H.R. 3003, Section 2, the "No Sanctuary for Criminals Act, which would penalize law enforcement agencies by withholding Federal fudning from so-called sanctuary cities; H.R. 3089/S. 1454, the Corporate Transparency Act, would require the Federal government to collect beneficial ownership information for corporations and limited liability companies unless the State already collects this information; H.R. 3249, the Project Safe Neighborhoods Grant Program Authorization Act, would reauthorize and fully fund the Project Safe Neighborhoods program; H.R. 3790/S. 1854, the Federal Firearms Licensee Protection Act, which would increase penalties on those who burglarize or rob a Federal Firearms Licensee; H.R. 4471/S. 2492, the NICS Denial Notification Act, would require the U.S. Department of Justice to notify State and local law enforcement agencies if a prohibited person attempts to purchase a firearm in their jurisdiction; H.R. 4477/S. 2135, the "Fix NICS Act, would require all Federal agencies and States to produce NICS implementation plans focused on uploading accurate, required information to the background check system; H.R. 4768/S. 2715, the National Strategy for Combating the Financing of Transnational Criminal Organizations Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; H.R. 4854/S. 2345, the Justice Served Act, which will increase the capacity of prosecutors to address the backlog of violent crime cases involving suspects identified through DNA evidence; H.R. 5060, the Heroes Lesley Zerebney and Gilbert Vega First Responders Survivors Support Act, which would increase the amount of the death benefit provide by the Public Safety Officers benefits (PSOB) program as well as other benefits administered by the PSOB; H.R. 5219, the Opioid Prescription Verification Act, which would require retail sellers of opioids to verify the identity of the purchaser; H.R. 5682 (as introduced), the Formerly Incarcerated Reenter Society Transformed Safely Transitioning Every Person (FIRST STEP) Act, which may result in the premature release of thousands of convicted offenders; H.R. 5698/S. 2794, the Protect and Serve Act, which would make it a Federal crime to target a law enforcement with an assault that results in seriously bodily harm or death; H.R. 5788, the Securing the International Mail Against Opioids Act, which would close the loophole and allow U.S Custom and Border Protection to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 5871/S. 2763, the "Providing Officers with Electronic Resources (POWER) Act, which would establishes a grant program to be administered by the Office of Community Oriented Policing Services (COPS) in order to provide State and local law enforcement agencies with portable chemical screening devices to detect dangerous synthetic opioids and other drugs; S. 207, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, would close the existing loophole for the manufacturers on analogue drug sales and distribution; S. 318, the COPS Improvement Act, would reauthorize the Office of Community Oriented Policing Services (COPS) and improve its existing hiring program; S. 446, the Constitutional Concealed Carry Reciprocity Act, which would allow any civilian concealed carry permit holder to travel to any other State issuing concealed carry permits without any training or safety requirements; S. 739, the Protecting Kids from Candy-Flavored Drugs Act, would impose increased prison sentences on adults who manufacture, create, distribute, or possess with the intent to distribute a controlled substance that is appealing to kids, whether designed or flavored; S. 748, the Protecting the Rights of Families and Immigrants Who Legally Entered From Detention (PROFILED) Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search, absent an eyewitness description, and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; S. 1241, the Combating Money Laundering, Terrorist Financing, and Counterfeiting Act, which would update and strengthen Federal laws to combat money laundering and provide law enforcement with additional tools to restrict the ability of criminals to profit from their crimes; S. 1311, the Abolish Human Trafficking Act, reauthorizes parts of the Trafficking Victims Protection Act and expand the authority of State and local agencies to obtain wiretap warrants for trafficking investigations; S. 1312, the Trafficking Victims Protection Act, would help prevent human trafficking by promoting training for law enforcement and school resource officers through the Office of Community Oriented Policing Services (COPS) to better identify and respond to human trafficking victims; S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; S. 1666, the "Helping Overcome Trauma for Children Alone in Rear Seats (HOTCARS) Act, which would direct the U.S. Department of transportation to implement a rule requiring vehicles to notify drivers if a child or other passenger has been inadvertently left behind; S. 1781, the National White Collar Crime Control Act, which would reauthorize grant programs to law enforcement to combat white collar crimes; S. 2389, Erics Law, which would amend current law to allow Federal prosecutors to impanel a second jury for the sentencing phase of capital cases; S. 2715, the Criminal Organizations Narcotics, Finance, Resources, Operations and Network Targeting (CONFRONT) Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; S. 2759, the EAGLES Act, which would reauthorize the National Threat Asessment Center (NTAC) within the U.S. Department of Homeland Security; S. 2774, which would reauthorize the Office of Community Oriented Policing Services (COPS) within the U.S. Department of Justice through 2023; S. 2789, the "Substance Abuse Prevention Act, which would reauthorize the Office of National Drug Control Policy and the programs it administers; S. 2973, the Kelsey Smith Act, which would require telephone companies and wireless carriers to disclose cell-site location data without a warrant in certain exigent circumstances; Legislation which would protect the personal information of law enforcement officers and their families from public access; Legislation or amendments that would have the effect of weakening PL 106-185, the Civil Asset Forfeiture Reform Act of 2000; Legislation which would create or fund civilian review boards of law enforcement at any level of government; and Legislation which would further normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.